poisar

Stock

Profound Medical Corp. PROF

$6.63-0.60%

Overview

PROF market data

Price History

PROF price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$1.41
Diluted earnings per share over the trailing twelve months.
Beta
2.05
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-206.8%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$5.23 – $12.40
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $376.3M · P/B 3.23 · P/S 14.35.

Company News

3 captured
Profound Medical Affirms FY2026 Sales Guidance of $25.000M vs $26.858M EstBenzinga · Aug 6, 2026, 8:50 PM
Profound Medical Q2 EPS $(0.26), Inline, Sales $2.483M Miss $5.500M EstimateBenzinga · Aug 6, 2026, 8:20 PM
8-K filing — Profound Medical Corp. (PROF)SEC EDGAR · Jul 24, 2026, 3:58 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock